Diagnosing Alzheimer’s Disease in 2026: From Clinical Criteria to Biomarker Confirmation

60 min
Saturday, December 05, 2026
9:20 AM - 10:20 AM
Diagnosis of Alzheimer’s disease is rapidly evolving with the integration of biomarkers into clinical workflows. This session reviews current diagnostic criteria and examines how biomarker confirmation is reshaping early and accurate diagnosis across care settings.
  • Room
    • Windsong 1-4
share
Back to top